Core Insights - Cryoport, Inc. has launched a new state-of-the-art facility in Louvres, France, enhancing its Global Supply Chain Center network to support complex life sciences supply chain needs [1][2][4] - The facility is strategically located near Paris Charles de Gaulle Airport and will provide end-to-end temperature-controlled supply chain solutions for biopharma and other temperature-sensitive commodities [2][3] - The facility will be operational immediately, offering logistics support for various therapies and will expand its services over time to include BioServices and biostorage [3][4] Company Expansion - The new facility is the third global supply chain center in Cryoport's network, aimed at streamlining operations in the advanced therapies market [2] - It will enhance Cryoport's ability to serve clients in European and global markets, ensuring secure handling of temperature-sensitive commodities [4] - The facility's operations will include 24-hour worldwide dispatch capabilities and will align with Cryoport's quality oversight standards [4] Future Developments - An official grand opening for the Paris GSCC is scheduled for November 20, 2025, which will involve local dignitaries and market leaders in the advanced therapies sector [5] - The facility was partially funded by a grant from the Île-de-France region to promote economic growth in the area [4]